SEC-sourced researchBeta
INSP
Inspire Medical Systems, Inc.
Company comparison ↗
Data passport
- CIK
- 0001609550
- Exchange
- NYSE
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Sep 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 624,799,000.0000 | Feb 13, 2026 |
| December 2024 | 802,804,000.0000 | Feb 13, 2026 |
| December 2025 | 911,981,000.0000 | Feb 13, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 911,981,000.0000 | 145,422,000.0000 | 116,976,000.0000 | 907,317,000.0000 | 126,157,000.0000 | Feb 13, 2026 |
| December 2024 | 802,804,000.0000 | 53,509,000.0000 | 130,246,000.0000 | 808,383,000.0000 | 118,688,000.0000 | Feb 13, 2026 |
| December 2023 | 624,799,000.0000 | -21,153,000.0000 | 24,653,000.0000 | — | — | Feb 13, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $911.98M | December 2025 | Feb 13, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $802.8M | December 2024 | Feb 13, 2026 | 10-K |
| Net incomeNetIncomeLoss | $145.42M | December 2025 | Feb 13, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $116.98M | December 2025 | Feb 13, 2026 | 10-K |
| Total assetsAssets | $907.32M | December 2025 | Feb 13, 2026 | 10-K |
| Total liabilitiesLiabilities | $126.16M | December 2025 | Feb 13, 2026 | 10-K |